Streptococcus pneumoniae infection is recognized as a global priority public health problem, and conjugate vaccines have been shown to prevent vaccine-type invasive pneumococcal disease (IPD) in children. However, better estimates of the disease burden and reliable population-based data on serotype composition are needed for vaccine development and implementation in developing countries.
. Case definitions used at study enrollment for possible pneumococcal diseases.
Diagnosis
Patient age Definition Pneumonia 2-59 Months Tachypnea a and cough and/or difficult breathing
Severe pneumonia 2-59 Months Tachypnea a and cough and/or difficult breathing AND chest indrawing and no danger signs Very severe disease !5 Years Presence of danger signs with or without pneumonia; if the child has a meningitis clinical syndrome, refer to the case definitions for meningitis; danger signs include inability to drink or breast-feed, convulsions, prostration and/or lethargy (abnormally sleepy or difficulty waking), severe malnutrition, stridor in a calm child, hypothermia (temperature, р35.5؇C) or fever (temperature, у39؇C), fast breathing (if !2 months of age), chest indrawing (if !2 months of age), and central cyanosis Meningitis !5 Years Sudden onset of fever and at least 1 of the following: stiff neck, altered consciousness and/or reduced level of consciousness, bulging fontanelle (if !12 months of age), prostration and/or lethargy, convulsions, toxic appearance, petechial or purpural rash, poor sucking, and irritability (if 12 months of age) a Defined as у50 breaths/min for children aged у2 months but !12 months and as у40 breaths/ min for children aged у12 months but !5 years.
emergence of multidrug-resistant S. pneumoniae [13] [14] [15] [16] have contributed to the recent increased interest in pneumococcal vaccine research. Substantial progress has been made in the development of pneumococcal polysaccharide and protein conjugate vaccines, and clinical trials have shown some impressive results in protecting children against vaccine-type pneumococcal disease, pneumonia, and meningitis in the United States [17, 18] and South Africa [19, 20] and have led to reductions in all-cause mortality among children in The Gambia [21] .
In the United States, Levine et al. [22] have reinforced the previous recommendation of the Centers for Disease Control and Prevention Advisory Committee [23] for an immediate and universal administration of the heptavalent pneumococcal conjugate vaccine to children. However, in a developing area, such as Bangladesh, where data are limited to only a few hospital-based studies and where S. pneumoniae is not widely recognized as a priority public health problem, this knowledge gap is a substantial barrier to any decision to incorporate a pneumococcal vaccine into public health practice. The situation is further complicated by the fact that available data from Bangladesh on the serotype distribution of invasive pneumococcal strains indicate a poor coverage with established vaccine formulations, including the 11-valent conjugate vaccine [14, 24] . With assistance from the Pneumococcal Vaccines Accelerated Development and Introduction Plan (PneumoADIP) [25] , an extensive hospital and population-based surveillance was initiated in 2004 to assess the burden associated with IPD. We present here data from the first 3 years of a population-based surveillance for IPD in a rural community of Bangladesh. We provide information on IPD incidence, seasonal variations, drug-resistance patterns, and serotype composition associated with community-acquired disease in children in this rural Bangladesh community.
PATIENTS, MATERIALS, AND METHODS
Study population, sample size and sampling procedure. The surveillance was set-up in Mirzapur, a rural subdistrict of Bangladesh, located 60 km north of the capital, Dhaka. Mirzapur has an estimated population of 400,000, distributed in 13 unions and 219 villages. The estimated annual birth cohort is 11,000. The area is served by a 750-bed nonprofit private hospital (Kumudini Hospital; Mirzapur, Bangladesh) and a 31-bed government Upazilla (subdistrict) Health Complex, each with laboratory and radiograph facilities.
Six of the 13 unions of Mirzapur were previously selected at random for a neonatal health intervention study, and the same 6 unions also formed the population for this surveillance. The study population was further divided into 72 clusters with ∼2000 population (175-190 children !5 years of age) each. All children !5 years of age (excluding neonates 0-28 days of age) who resided in those clusters were enrolled in the surveillance. Informed consent was obtained from the parents or guardians of the children. This was an open cohort, and children who were born or migrated into the study area were enrolled on a continuing basis. The surveillance sample size was based on an expected rate of 0.23 episodes of IPD-like illness per year among a cohort of ∼10,080 children under surveillance (i.e., 2318 episodes per year). This figure was derived from the known !5-year acute lower respiratory infection incidence in rural Matlab [26] , an area 105 km southeast of Mirzapur. With this estimate, we expected ∼2300 blood cultures annually from the study site.
The surveillance started in July 2004. We here present the findings from the surveillance for the period from July 2004 through June 2007.
Outcome variables, case definitions, and data collection. A trained village health care worker (VHW) was assigned to each of the 72 clusters for active surveillance of enrolled children. The workers visited every household with an enrolled child !5 years of age once per week and asked the mother (or caretaker) of the child whether the child was experiencing any illness at the time of the visit. If the child was reported to be ill, the mother was then asked about the symptoms. If the mother reported that the child had fever or cough or difficult breathing, then the child was clinically assessed by the VHW. The worker used an algorithm to classify children's illnesses that was adapted from the guidelines for the Integrated Management of Childhood Illness developed by the World Health Organization [27 ] . Children classified as having possible severe pneumonia (rapid breathing for children !2 months of age or rapid breathing with at least 1 danger sign for children 2-59 months of age), suspected meningitis or very severe disease (fever plus stiff neck, bulging fontanelle, inability to feed, convulsion, being lethargic or abnormally sleepy or being difficult to wake, and vomiting), or high fever and/or possible bacteremia (axillary temperature, у38.8ЊC for children у2 months of age or у38.3ЊC for children !2 months of age, as measured by the VHW) were referred to Kumudini Hospital. Rapid breathing was defined on the basis of World Health Organization age-specific criteria [27 ] as у60 breaths/min for children !2 months of age, у50 breaths/min for children 2-11 months of age, and у40 breaths/min for children 12-59 months of age. Danger signs included convulsion, lower chest indrawing, being lethargic or abnormally sleepy or being difficult to wake, being unconscious, inability to feed, and vomiting.
All children from the surveillance area who sought care for illness from Kumudini Hospital, including those children who were referred by the VHWs, are included in this analysis. Children were examined by study physicians in the outpatient department of the hospital and, from March 2006, were also examined in the emergency department. Blood samples were collected for culture by a study nurse from children who were admitted to the hospital with suspected pneumonia, severe pneumonia, very severe disease, high fever (temperature, 138ЊC), or meningitis. A CSF sample was also collected by a study physician for culture in case of meningitis or very severe disease. However, on-duty clinicians also exercised their judgment when deciding whether or not blood and/or CSF samples would be collected. Study physicians enrolled children who met standardized surveillance case definitions (table 1) and used standardized forms to obtain and record clinical information from these children. From July 2005, children who were not admitted to the hospital but who otherwise met the case definitions had a blood sample collected for culture if consent was given. IPD was confirmed on the basis of isolation of the organism from blood and/or CSF. Conventional blood culture bottles with trypticase soy broth supplemented with 0.025% SPS and 1% isovitalex were inoculated with 2-3 mL of blood, incubated at 37ЊC, and subcultured on days 1, 3, and 5. Isolates were identified, tested for susceptibility to antibiotics, and serotyped in accordance with the standard procedures [14, 24, 28, 29] . Further details of the methods are provided in Saha et al . [30] .
Although a set of standardized surveillance case definitions (table 1) were used by the study physicians for case ascertainment and enrollment, a revised set of case definitions (table 2) were used during analysis to ensure consistency with other published data. The major differences between the 2 sets of case definitions include the addition of "very severe pneumonia" and "bacteremia" classifications in the revised case definitions. Most individuals who were classified as having "very severe disease" (with pneumonia) according to the previous case definitions were classified as having "very severe pneumonia" according to the new case definitions. The new case definitions also did not require the presence of rapid breathing to classify a patient as having severe pneumonia. History of cough and/or difficulty breathing, accompanied by chest indrawing alone, was sufficient to classify a case as severe pneumonia. The new case definitions addressed the issue of a decrease in respiratory rate in individuals with severe cases who may present with only chest-indrawing. To exclude febrile convulsion, the new case definition of meningitis also now considers the type of seizure and the age of the child. Finally, the new case definitions have eliminated temperature у39ЊC as an entry criteria for the application of the various case definitions.
Data analysis. Statistical analysis was performed using Stata, version 8.0 (Stata). A child started to contribute to person-time as soon as consent was given. Children stopped contributing to person-time if they died, moved out of the study area, or reached the age of 60 months. Person-time was calculated on the basis of the assumption that each weekly visit was equivalent to 7-day follow-up of every child. For calculating incidence rates, the number of isolates was divided by the childyears of observation. The incidence for each of the months was averaged over the 3 years of follow-up and was plotted to indicate seasonality pattern.
The protocol was approved by the Ethical Review Committee of the International Centre for Diarhoeal Disease Research, Bangladesh.
RESULTS
From July 2004 through June 2007, a total of 22,378 children were enrolled in the surveillance (table 3) . During this period, the mean number of children seen each week by the VHWs was 10,201, which contributed to an estimated 30,392 personyears of follow-up. VHWs assessed 64,388 episodes of reported illness in these children and referred 13,895 episodes in a total of 7259 children to Kumudini Hospital. An additional 5398 cases were referred by VHWs for moderate fever. At the hospital, there were 17,353 visits at the outpatient and emergency departments of the hospital by children enrolled in the surveillance. Of these visits, 15,860 were referrals by VHWs (including 4491 in which the child had only moderate fever), and 1493 children came to the hospital without a referral. Among the children seen at the hospital, 2596 were admitted. A total of 6925 blood samples and 41 CSF samples were obtained from these children at outpatient and emergency department visits and by inpatient departments. In table 4 , we present the illness classification of the children as assessed by the VHWs. The VHWs identified 2029 cases of suspected meningitis or very severe disease, 5020 possible cases of severe pneumonia, and 8967 cases of high fever and/or possible bacteremia. The VHWs were trained to refer these cases to the hospital, and this resulted in 13,895 referrals, because many of the children had 11 illness classification. The incidence rate for all classifications decreased with age, with the highest rates among children !1 year of age.
From the total of 6925 blood cultures and 41 CSF cultures of samples from hospitalized patients, outpatients, and patients seen at emergency department visits, 93 organisms were isolated (isolation rate, 1.34%) (tables 3 and 5). More than two-thirds of the isolates were Salmonella typhi (39% of isolates) and S. pneumoniae (28%). Haemophilus influenzae type b (Hib) accounted for 12% of the isolates. S. pneumoniae was most common among children !2 years of age, whereas Hib was found mostly in children !1 year of age. On the other hand, S. typhi was found only among children 1-4 years of age and was particularly common among children 12 years of age.
Of the 2596 total hospital admissions, 817 were for pneumonia, 78 were for severe pneumonia, and 82 were for very severe pneumonia. There were 175 hospital admissions for meningitis, 13 hospital admissions in which the illness was classified as very severe disease, and 20 cases of bacteremia as defined in table 1 (table 6 ). In addition, 74 hospitalized children with fever and another 700 children with conditions defined as "other" are also included in this analysis. The condition "other" included those children who did not meet the case definitions of pneumonia, meningitis, very severe disease, or bacteremia. Table 6 also provides estimates of cause-specific hospitalization rates. S. pneumoniae was isolated from 13 of the children who were admitted to the hospital with pneumonia, very severe pneumonia, meningitis, or bacteremia. Thirteen S. pneumoniae isolates were obtained from patients seen at outpatient or emergency department visits. This included 8 isolates obtained from patients who received a diagnosis of upper respiratory tract infection and another 5 isolates from patients with fever. Five of these 13 patients received amoxicillin, 5 received trimethoprim-sulfamethoxazole, and 1 received ce- phradine. Four of these outpatients still had symptoms when they were assessed by VHWs at their routine weekly follow-up visits. Two of these patients were referred again to Kumudini Hospital, but only 1 of them complied with the referral; that patient was treated again with trimethoprim-sulfamethoxazole and recovered. Twenty-five S. pneumoniae isolates were obtained from blood cultures, and 1 was obtained from a CSF culture, giving an IPD rate of 86 cases per 100,000 child-years observed (table 7) . This rate would have been only 43 cases per 100,000 child-years if only hospitalized patients were included. This estimate would be 98 cases per 100,000 child-years if data for 2004 are ignored, when the newly established laboratory was not fully functional. Also, if only the period from April 2006 (when the outpatient surveillance became fully functional) through June 2007 is considered, the estimate increases to 108.1 cases per 100,000 childyears. Eight Hib isolates were obtained from blood cultures, and 3 were obtained from CSF cultures (from a total of 8 children), giving a Hib disease rate of 36 cases per 100,000 child-years observed. A seasonal variation of IPD incidence was seen, with a prominent peak in March and another moderate peak in September. This apparent seasonality could be greatly influenced by random variation, given the small number of isolates obtained ( figure 1) .
Serotypes 1, 5, 14, 18C, 19A, and 38 comprised more than three-fourth of the S. pneumoniae isolates; serotypes 5, 14, and 19A were the most common serotypes (table 8). The S. pneumoniae isolates were found to be completely susceptible to chloramphenicol, ampicillin, and ceftriaxone (table 9) . Susceptibility to ciprofloxacin was also high (96%). In contrast, only 23% of the S. pneumoniae isolates were susceptible to trimethoprim-sulfamethoxazole; 38% were resistant, and 38% had reduced susceptibility. Susceptibility to gentamicin was even lower (11% of isolates).
DISCUSSION
This population-based active case surveillance study in rural Bangladesh provides valuable estimates of the burden of IPD. Individuals with possible cases were actively detected in the community through weekly home visits and were referred to a hospital serving the population, and individuals seen at the hospital had their cases investigated. We have a better understanding of the antimicrobial susceptibility and the serotype distribution of invasive S. pneumoniae strains, the latter having a direct relationship with possible vaccines. Almost all available evidence of IPD burden is from surveillance studies performed in hospitals and health care facilities, with some populationbased data from the control arms of large vaccine trials [7, 9, 21, [31] [32] [33] . Seeking care from health care facilities is uncommon in Bangladesh; therefore, community-based active surveillance is the only means for providing good estimates of disease burden [3] .
The surveillance in the Mirzapur community was designed to identify and refer children with possible severe pneumonia, meningitis and/or very severe disease, and high fever (possible bacteremia). Although the incidence of possible severe pneu- All serotypes 14 (100) 9 (100) 1 (100) 1 (100) 1 (100) 26 (100) 1 monia and meningitis and/or very severe disease was highest in the first year of life and decreased with age, high fever was most common among children 12-23 months old. The overall incidence of pneumonia (including both severe and nonsevere pneumonia) was 0.47 episodes per child-year, which is substantially higher than the incidence of 0.23 episodes per childyear reported from another Bangladesh rural area (Matlab) for the period 1988-1999 [26] . One basic difference between the 2 sites is that, in Matlab, episodes were defined on the basis of a minimum of 7 illness-free days between episodes with use of data collected at twice-weekly home visits, whereas in Mirzapur, illness seen at each of the weekly home visits was considered to be a separate episode. The age distribution of patients with S. pneumoniae and Hib isolates was consistent with reports from other countries, with Hib isolates being obtained almost exclusively from children !1 year of age and S. pneumoniae isolates being obtained most often from children !2 years of age. This suggests that administration of Hib and S. pneumoniae vaccines in early infancy should be very effective in reducing much of the disease burden caused by S. pneumoniae and Hib [34] . We did not observe any obvious seasonal patterns of IPD, although a larger sample of isolates might reveal such a pattern.
We note that 13 of the 26 S. pneumoniae isolates were obtained from children who were seen as outpatients or in emergency departments but were not hospitalized, which raises the question of the severity of these cases. Eleven of these nonhospitalized patients were given antibiotics, and 2 of them had to be rereferred to Kumudini Hospital. It is possible that these cases may have had the potential to become severe illnesses but were identified and treated early, probably because of the active population surveillance. The original plans for the surveillance in Mirzapur did not include performing blood cultures on samples obtained from nonhospitalized patients. The fact that 50% of the S. pneumoniae isolates were obtained from nonhospitalized patients confirms that S. pneumoniae infection can result in invasive but apparently nonsevere disease, and if such conditions are overlooked, the total disease burden will be seriously underestimated. The overall incidence of IPD is 86 cases per 100,000 child-years of observation, whereas if outpatient cases are excluded, the incidence decreases to 43 cases per 100,000 child-years of observation. This finding supports the hypothesis that the variation in rates of IPD in socioeconomically similar regions, such as Western Europe and North America, can be attributed to different blood culture practices, especially in the outpatient departments [35] . This can result in underdiagnosis and underreporting of mild IPD in some populations. We note here that, of the outpatient cases yielding S. pneumoniae, approximately one-half were diagnosed as upper respiratory tract infection, and the rest were diagnosed as viral fever. On the other hand, S. pneumoniae was isolated in 0.2% of the outpatient cases, which is much lower than the 1% S. pneumoniae isolation rate among the hospitalized children.
Hospitalized children yielded 13 of the 26 S. pneumoniae isolates (12 from blood cultures and 1 from a CSF culture). Although 2 of the 13 S. pneumoniae isolates were from patients with pneumonia, none of the patients with severe pneumonia yielded an isolate. We note that only 17% of the hospitalized children with pneumonia or severe pneumonia had a blood culture performed. This may partly explain the lack of any S. pneumoniae isolates from these patients, because on the basis of the 1% isolation rate, the 79 cultures performed could be expected to yield !1 isolate. The decision as to whether a blood sample would be obtained from a particular patient was made by the hospital pediatrics team, and in many instances, they did not feel that the clinical situation warranted a blood culture, despite the suggestion of the PneumoADIP-agreed case definition. We may also hypothesize that the children admitted to the hospital with pneumonia and/or severe pneumonia more closely reflected the cases seen in the outpatient department. These children yielded invasive S. pneumoniae isolates at a lower rate than did other children hospitalized with more-severe illness and may have proceeded to more-severe illness with a greater likelihood of yielding an S. pneumoniae isolate if they had not been actively traced in the community, referred to the hospital, and admitted for treatment.
We report an overall incidence of IPD of 86 cases per 100,000 child-years. This estimate of invasive pneumoccal disease burden is consistent with findings from other populations in Africa and Latin America, where rates ranging from 15 cases per 100,000 child-years in Mali [7] to 34 cases per 100,000 childyears in Chile [31] , 171 cases per 100,000 child-years in The Gambia [8] , 436 cases per 100,000 child-years in Kenya [36] , and 447 cases per 100,000 child-years in Kamalapur, Bangladesh [37] , have been reported. It is not clear what explains this variation in the reported incidence of IPD. There are differences in case detection procedures, eligibility criteria, case definitions, and laboratory techniques in these studies. However, there are also likely to be true differences in disease incidence.
We observed a predominance of serotypes 1, 5, 14, 18C, 19A, and 38. Of these, serotype 38 has not, to our knowledge, been reported as a common serotype in previous studies from Bangladesh [14] . Of the serotypes covered in the 7-valent pneumococcal conjugate vaccine available on the market (containing pneumococcal capsular polysaccharide serotypes 4, 6B, 9V, 14, 18C, 19F, and 23F), only serotypes 14 and 18C were found in this community, and they accounted for only 31% of all the isolates [17] . Serotype coverage for the newer 10-valent (7-valent pneumococcal conjugate vaccine antigens plus serotypes 1, 5, and 7F) and 13-valent (10-valent pneumococcal conjugate vaccine antigens plus serotypes 3, 6A, and 19A) vaccines are 58% and 69% of all IPDs, respectively. Currently available vaccines do not provide good coverage of invasive pneumococcal strains in this community, although the coverage is substantially higher with vaccines that are in development. Even if the current vaccine is introduced into the large birth cohort (∼4 million) in Bangladesh, this would result in the prevention of a large number of IPD cases. However, because a number of strains that are prevalent in Bangladesh are not included in the current vaccines or in upcoming vaccine candidates, we expect that a substantial number of cases of IPD would continue to occur in Bangladesh. Therefore, a vaccine formulation that would provide species-wide coverage or include substantially more serotypes would provide the greatest public health benefit.
The Government of Bangladesh continues to recommend trimethoprim-sulfamethoxazole as the first-choice antibiotic for the presumptive treatment of pneumonia. Previous reports (from the urban area of Dhaka, India, and largely involving meningitis cases) indicated that almost two-thirds of strains were resistant to trimethoprim-sulfamethoxazole [14] . In the Mirzapur rural community, nearly 80% of the S. pneumoniae isolates were resistant to or exhibited reduced susceptibility to trimethoprim-sulfamethoxazole. The high level of resistance of S. pneumoniae to trimethoprim-sulfamethoxazole is an issue to be addressed. There are reports that indicate that in vitro antimicrobial resistance and clinical effectiveness are sometimes different for trimethoprim-sulfamethoxazole [38] , and this argument has been used to justify the continued use of trimethoprim-sulfamethoxazole for the treatment of community-acquired pneumonia. In this population, more of the inpatient isolates were completely resistant to trimethoprim-sulfamethoxazole (53% of inpatient isolates vs. 23% of outpatient isolates) (data not shown). This emphasizes the need to revisit the current World Health Organization recommendations of trimethoprim-sulfamethoxazole as the antibiotic of choice for treating nonsevere pneumonia in the community.
There are 4 main factors that may have contributed to an underestimation of the true magnitude of IPD in Mirzapur. First, as mentioned earlier, the once per week home visits may have missed cases in children whose parents sought care from other health care providers, although at this time, we do not have data on the number of such children. A proportion of children also visit government and other health care facilities. Unfortunately, we did not collect any data from these facilities. Second, because our VHWs were not offering any treatment but only referral, there was very little incentive for the community to actively seek their help in case of childhood illness. Third, blood cultures were not performed for all eligible cases and would have contributed some cases of IPD that were missed. Fourth, current blood culture techniques remain of low sensitivity and do not identify all IPD cases. Blood cultures may be augmented by other techniques, such as PCR and latex agglutination, that substantially improve the yield of cases of IPD.
When a 9-valent pneumococcal vaccine was evaluated in The Gambia, the reduction in the prevalence of radiological pneumonia and IPD was much larger than was predicted from the previously known distribution of pneumococcal serotypes in The Gambia [21] . In Bangladesh, we have observed shifts in the serotype distribution over time [14, 16, 24] . This cannot be attributed to vaccine-induced serotype replacement, because pneumococcal conjugate vaccine is not widely used in this community. Consequently, a pneumococcal conjugate vaccine probe study may provide the best possible disease burden estimate for a developing country, such as Bangladesh. However, caution must be used in interpreting any shift of serotype in the future, after the introduction of the pneumococcal conjugate vaccine [30] .
We believe that the findings from this study have provided confirmation that IPD contributes substantially to childhood illness in Bangladesh. One-half of the IPD cases were in children who were seen as outpatients (in particular, children with symptoms of upper respiratory infection or fever). Prevention through the administration of appropriate vaccines in the public health system and high coverage of treatment of possible cases with appropriate antibiotics is imperative.
